GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veeva Systems Inc (NYSE:VEEV) » Definitions » Altman Z2-Score

Veeva Systems (Veeva Systems) Altman Z2-Score : 10.28 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Veeva Systems Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Veeva Systems has a Altman Z2-Score of 10.28, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Veeva Systems's Altman Z2-Score or its related term are showing as below:

VEEV' s Altman Z2-Score Range Over the Past 10 Years
Min: 6.98   Med: 8.81   Max: 10.28
Current: 10.28

During the past 13 years, Veeva Systems's highest Altman Z2-Score was 10.28. The lowest was 6.98. And the median was 8.81.


Veeva Systems Altman Z2-Score Historical Data

The historical data trend for Veeva Systems's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veeva Systems Altman Z2-Score Chart

Veeva Systems Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.96 8.75 9.65 9.85 10.28

Veeva Systems Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.85 10.14 10.45 12.23 10.28

Competitive Comparison of Veeva Systems's Altman Z2-Score

For the Health Information Services subindustry, Veeva Systems's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veeva Systems's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Veeva Systems's Altman Z2-Score falls into.



Veeva Systems Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Veeva Systems's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.647+3.26*0.4636+6.72*0.0995+1.05*3.6686
=10.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jan. 2024:
Total Assets was $5,911 Mil.
Total Current Assets was $5,003 Mil.
Total Current Liabilities was $1,179 Mil.
Retained Earnings was $2,740 Mil.
Pre-Tax Income was 182.693 + 170.676 + 142.875 + 91.778 = $588 Mil.
Interest Expense was 0 + 0 + 0 + 0 = $0 Mil.
Total Liabilities was $1,266 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(5003.211 - 1178.883)/5910.92
=0.647

X2=Retained Earnings/Total Assets
=2740.457/5910.92
=0.4636

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(588.022 - 0)/5910.92
=0.0995

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(4644.824 - 0)/1266.096
=3.6686

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Veeva Systems has a Altman Z2-Score of 10.28 indicating it is in Safe Zones.


Veeva Systems  (NYSE:VEEV) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Veeva Systems Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Veeva Systems's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Veeva Systems (Veeva Systems) Business Description

Address
4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Executives
Thomas D. Schwenger officer: President and COO C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Alan Mateo officer: EVP Global Sales C/O VEEVA SYSTEMS, 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Eleni Nitsa Zuppas officer: Chief Marketing Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Matthew J Wallach officer: President C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Mary Lynne Hedley director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Timothy S Cabral officer: Chief Financial Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Paul J Sekhri director C/O VEEVA SYSTEMS INC., 4637 CHABOT DRIVE, SUITE 210, PLEASANTON CA 94588
Kristine Diamond officer: Chief Accounting Officer 345 ENCINAL STREET, SANTA CRUZ CA 95060
Paul Edward Chamberlain director C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Michele O'connor officer: Chief Accounting Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Peter P Gassner director, 10 percent owner, officer: Chief Executive Officer C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Codd Ronald E F director C/O INTERWOVEN INC, 803 11TH AVE, SUNNYVALE CA 94089
Nimrata Hunt director IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Priscilla Hung director C/O GUIDEWIRE SOFTWARE, INC., 970 PARK PL, SUITE 200, SAN MATEO CA 94403
Marshall Mohr director C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086